UnitedHealth Group (UNH) Competitors

$492.97
+8.86 (+1.83%)
(As of 05/2/2024 ET)

UNH vs. ELV, JNJ, NVO, MRK, ABBV, AZN, TMO, LLY, NVS, and ABT

Should you be buying UnitedHealth Group stock or one of its competitors? The main competitors of UnitedHealth Group include Elevance Health (ELV), Johnson & Johnson (JNJ), Novo Nordisk A/S (NVO), Merck & Co., Inc. (MRK), AbbVie (ABBV), AstraZeneca (AZN), Thermo Fisher Scientific (TMO), Eli Lilly and Company (LLY), Novartis (NVS), and Abbott Laboratories (ABT). These companies are all part of the "medical" sector.

UnitedHealth Group vs.

UnitedHealth Group (NYSE:UNH) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, community ranking, dividends, valuation and earnings.

UnitedHealth Group has higher revenue and earnings than Elevance Health. Elevance Health is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UnitedHealth Group$371.62B1.22$22.38B$16.3630.13
Elevance Health$171.34B0.71$5.99B$26.4619.86

UnitedHealth Group received 838 more outperform votes than Elevance Health when rated by MarketBeat users. Likewise, 80.50% of users gave UnitedHealth Group an outperform vote while only 66.61% of users gave Elevance Health an outperform vote.

CompanyUnderperformOutperform
UnitedHealth GroupOutperform Votes
1668
80.50%
Underperform Votes
404
19.50%
Elevance HealthOutperform Votes
830
66.61%
Underperform Votes
416
33.39%

UnitedHealth Group has a net margin of 4.05% compared to Elevance Health's net margin of 3.64%. UnitedHealth Group's return on equity of 26.50% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
UnitedHealth Group4.05% 26.50% 8.60%
Elevance Health 3.64%20.62%7.35%

87.9% of UnitedHealth Group shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.4% of UnitedHealth Group shares are held by company insiders. Comparatively, 0.4% of Elevance Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

UnitedHealth Group pays an annual dividend of $7.52 per share and has a dividend yield of 1.5%. Elevance Health pays an annual dividend of $6.52 per share and has a dividend yield of 1.2%. UnitedHealth Group pays out 46.0% of its earnings in the form of a dividend. Elevance Health pays out 24.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

UnitedHealth Group presently has a consensus price target of $570.05, suggesting a potential upside of 15.82%. Elevance Health has a consensus price target of $587.42, suggesting a potential upside of 11.97%. Given UnitedHealth Group's higher possible upside, equities analysts plainly believe UnitedHealth Group is more favorable than Elevance Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
UnitedHealth Group
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83
Elevance Health
0 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.92

In the previous week, UnitedHealth Group had 26 more articles in the media than Elevance Health. MarketBeat recorded 50 mentions for UnitedHealth Group and 24 mentions for Elevance Health. Elevance Health's average media sentiment score of 0.88 beat UnitedHealth Group's score of 0.04 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
UnitedHealth Group
15 Very Positive mention(s)
4 Positive mention(s)
9 Neutral mention(s)
15 Negative mention(s)
6 Very Negative mention(s)
Neutral
Elevance Health
11 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

UnitedHealth Group has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, Elevance Health has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500.

Summary

UnitedHealth Group beats Elevance Health on 13 of the 19 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UNH vs. The Competition

MetricUnitedHealth GroupHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$452.96B$65.09B$4.91B$17.40B
Dividend Yield1.55%1.38%2.88%3.58%
P/E Ratio30.0913.70207.8223.42
Price / Sales1.220.502,504.6710.39
Price / Cash16.2510.0446.9717.44
Price / Book4.903.434.824.91
Net Income$22.38B$3.04B$103.34M$964.63M
7 Day Performance-0.32%-1.04%3.76%1.09%
1 Month Performance7.45%1.54%-3.25%-2.21%
1 Year Performance-0.22%9.20%6.63%98.23%

UnitedHealth Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.7891 of 5 stars
$533.89
-0.6%
$587.42
+10.0%
+11.1%$124.09B$171.34B20.18104,900
JNJ
Johnson & Johnson
4.9189 of 5 stars
$146.84
+0.5%
$175.86
+19.8%
-7.6%$353.85B$85.16B9.15131,900
NVO
Novo Nordisk A/S
2.2097 of 5 stars
$126.92
+0.1%
$133.60
+5.3%
+208.8%$569.56B$33.71B46.9263,370News Coverage
MRK
Merck & Co., Inc.
4.7534 of 5 stars
$130.10
-0.8%
$131.33
+0.9%
+10.7%$329.55B$61.40B144.5672,000Earnings Report
Analyst Revision
ABBV
AbbVie
4.7105 of 5 stars
$161.52
+1.2%
$174.31
+7.9%
+5.2%$286.00B$54.32B47.9350,000Earnings Report
Analyst Report
Analyst Revision
AZN
AstraZeneca
1.7762 of 5 stars
$75.48
+0.4%
$81.00
+7.3%
+4.0%$234.02B$45.81B37.0089,900Short Interest ↑
Analyst Revision
TMO
Thermo Fisher Scientific
4.6845 of 5 stars
$576.87
+0.6%
$606.76
+5.2%
+4.9%$220.20B$42.86B37.00122,000Analyst Report
Insider Selling
LLY
Eli Lilly and Company
4.6942 of 5 stars
$737.33
+0.5%
$728.05
-1.3%
+91.4%$700.58B$34.12B127.1343,000Earnings Report
Analyst Report
Analyst Revision
NVS
Novartis
3.2017 of 5 stars
$97.10
-0.3%
$115.00
+18.4%
-4.9%$198.47B$47.73B13.1076,057
ABT
Abbott Laboratories
4.9951 of 5 stars
$107.29
-0.2%
$121.50
+13.2%
-4.3%$186.17B$40.11B33.42114,000

Related Companies and Tools

This page (NYSE:UNH) was last updated on 5/2/2024 by MarketBeat.com Staff

From Our Partners